Clinical Evaluation Research Unit at Kingston General Hospital
16
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
31.3%
5 terminated/withdrawn out of 16 trials
58.3%
-28.2% vs industry average
31%
5 trials in Phase 3/4
43%
3 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
VItamin C in Thermal injuRY: The VICToRY Trial
Role: lead
Nutrition and Exercise in Critical Illness
Role: lead
The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Randomized Trial
Role: collaborator
Phosphate Bioavailability Hormonal Response to a Breakfast Meal in Healthy Humans
Role: lead
International Nutrition Survey 2018
Role: collaborator
The Effect of Higher Protein Dosing in Critically Ill Patients
Role: lead
The EFFORT Trial and EFFORT Outcomes Sub-study (EFFORT-Outcomes)
Role: lead
Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients
Role: lead
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
Role: lead
VALIDation of Bedside Ultrasound of Muscle Layer Thickness of the Quadriceps in the Critically Ill Patient
Role: lead
PEP uP Protocol in Surgical Patients
Role: lead
The Effect of Higher Protein Dosing in Critically Ill Patients Ultrasound a Sub-study
Role: lead
Improving Partnerships With Family Members of ICU Patients
Role: lead
The Impact of a Low or High Phosphate Diet on Phosphate and Calcium Excretion in Healthy People
Role: lead
Promotion of Oesophageal Motility to Prevent Regurgitation and Enhance Nutrition Intake in ICU Patients.
Role: collaborator
Fish OIL Optimal dosE Determination Study
Role: collaborator
All 16 trials loaded